Green Memory Study
Alzheimer's Disease
Not Disclosed (Sponsor-led)Active
Key Facts
Indication
Alzheimer's Disease
Phase
Not Disclosed (Sponsor-led)
Status
Active
About ActivMed Practices and Research
ActivMed is a well-established, private clinical research site organization with a 30-year operational history in the New England region. It provides clinical trial services to a diverse sponsor base, from large pharmaceutical companies to local biotechs, specializing in neurology, psychiatry, dermatology, and primary care conditions. The company has adapted to decentralized trial trends by offering virtual trial capabilities and community-focused telehealth services, such as free memory screenings, to support patient recruitment and engagement. Its business model is entirely service-based, generating revenue from clinical trial contracts.
View full company profileTherapeutic Areas
Other Alzheimer's Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| Donanemab | Eli Lilly | Phase 3 |
| ALN-APP | Alnylam Pharmaceuticals | Phase 1 |
| Alzheimer's Disease Program | Roche | Various |
| UCB0022 | UCB | Phase 1 |
| Lecanemab (Leqembi) | Eisai | Commercial |
| ARO-MAPT | Arrowhead Pharmaceuticals | Pre-clinical |
| AMBAR® | Grifols | Clinical |
| Lu AG08854 (L1CAM mAb) | Lundbeck | Preclinical |
| P021 | Phanes Biotech | Preclinical |
| PB43D | Phanes Biotech | Preclinical |
| DNL919 | Denali Therapeutics | Phase 1b |
| BAN2802 | BioArctic AB | Preclinical |